227 related articles for article (PubMed ID: 36048007)
1. Effect of Hesperidin Supplementation on Liver Metabolomics and Gut Microbiota in a High-Fat Diet-Induced NAFLD Mice Model.
Li X; Yao Y; Wang Y; Hua L; Wu M; Chen F; Deng ZY; Luo T
J Agric Food Chem; 2022 Sep; 70(36):11224-11235. PubMed ID: 36048007
[TBL] [Abstract][Full Text] [Related]
2. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
3. Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice.
Wang X; Jin Y; Di C; Zeng Y; Zhou Y; Chen Y; Pan Z; Li Z; Ling W
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674860
[TBL] [Abstract][Full Text] [Related]
4. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
[TBL] [Abstract][Full Text] [Related]
7. The signatures of liver metabolomics and gut microbiota in high-fat diet fed mice supplemented with rhododendrol.
Li X; Wang Y; Yu C; Yao Y; Chen X; Deng ZY; Yao Z; Luo T
Food Funct; 2022 Dec; 13(24):13052-13063. PubMed ID: 36468583
[TBL] [Abstract][Full Text] [Related]
8.
Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
[TBL] [Abstract][Full Text] [Related]
9. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites.
Meng Q; Ma M; Zhang W; Bi Y; Cheng P; Yu X; Fu Y; Chao Y; Ji T; Li J; Chen Q; Zhang Q; Li Y; Shan J; Bian H
Gut Microbes; 2021; 13(1):1-27. PubMed ID: 33691599
[TBL] [Abstract][Full Text] [Related]
11. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice.
Chao J; Huo TI; Cheng HY; Tsai JC; Liao JW; Lee MS; Qin XM; Hsieh MT; Pao LH; Peng WH
PLoS One; 2014; 9(2):e96969. PubMed ID: 24918580
[TBL] [Abstract][Full Text] [Related]
12. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
Guo WL; Guo JB; Liu BY; Lu JQ; Chen M; Liu B; Bai WD; Rao PF; Ni L; Lv XC
Food Funct; 2020 Aug; 11(8):6818-6833. PubMed ID: 32686808
[TBL] [Abstract][Full Text] [Related]
13. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
[TBL] [Abstract][Full Text] [Related]
14. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg
Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
[TBL] [Abstract][Full Text] [Related]
16. Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation.
Chen H; Nie T; Zhang P; Ma J; Shan A
Life Sci; 2022 May; 296():120428. PubMed ID: 35218767
[TBL] [Abstract][Full Text] [Related]
17. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
18. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
19. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
20. Dietary calamondin supplementation slows the progression of non-alcoholic fatty liver disease in C57BL/6 mice fed a high-fat diet.
Shimizu K; Egusa Y; Nishimuta S; Fukumura Y; Yoshimura M; Inomoto T; Terada T; Tomita K; Nishinaka T
Int J Food Sci Nutr; 2021 May; 72(3):335-347. PubMed ID: 32862731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
